2.71 USD
↘ 0.01 (0.37%)AT CLOSE (11:59 AM EDT)
Context Therapeutics Inc. Common Stock
CNTXNASDAQ • USD
2.71
↗ 0.07 (2.73%)
POST MARKET (AS OF 04:23 PM EDT)
Post Market
AS OF 04:23 PM EDT
2.71
↗ 0.07 (2.73%)
Market: OPEN
Open?$2.74
High?$2.86
Low?$2.68
Prev. Close?$2.72
Volume?441.5K
Avg. Volume?893.1K
VWAP?$2.78
Rel. Volume?0.49x
Bid / Ask
Bid?$2.66 × 100
Ask?$2.80 × 100
Spread?$0.14
Midpoint?$2.73
Valuation & Ratios
Market Cap?249.9M
Shares Out?91.9M
Float?67.5M
Float %?73.5%
P/E Ratio?N/A
P/B Ratio?4.13
EPS?-$0.39
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.52Strong
Quick Ratio?8.52Strong
Cash Ratio?8.23Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?4.13FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.6CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-59.7%WEAK▾
ROA?-52.7%WEAK▾
Cash Flow & Enterprise
FCF?$-26419328
Enterprise Value?$183.9M
Related Companies
Loading...
News
Profile
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Employees
15
Market Cap
249.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-20
Address
2001 MARKET STREET
PHILADELPHIA, PA 19103
Phone: 267-225-7416
PHILADELPHIA, PA 19103
Phone: 267-225-7416